Mebendazole
- Generic Name
- Mebendazole
- Brand Names
- Emverm, Vermox
- Drug Type
- Small Molecule
- Chemical Formula
- C16H13N3O3
- CAS Number
- 31431-39-7
- Unique Ingredient Identifier
- 81G6I5V05I
Overview
A benzimidazole that acts by interfering with carbohydrate metabolism and inhibiting polymerization of microtubules. [PubChem]
Background
A benzimidazole that acts by interfering with carbohydrate metabolism and inhibiting polymerization of microtubules. [PubChem]
Indication
For the treatment of Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections.
Associated Conditions
- Ancylostoma caninum infection
- Ancylostoma duodenale infection
- Ascaris lumbricoides infection
- Capillariasis
- Enterobius vermicularis infection
- Filariasis
- Giardiasis
- Necatoriasis due to necator americanus
- Strongyloides Stercoralis Infection
- Taenia solium infection
- Toxocariasis
- Whipworm infection
Clinical Trials
FDA Approved Products
VERMOX
Manufacturer:Janssen Pharmaceuticals, Inc.
Route:ORAL
Strength:500 mg in 1 1
Approved: 2021/09/30
NDC:50458-675
MEBENDAZOLE
Manufacturer:Physicians Total Care, Inc.
Route:ORAL
Strength:100 mg in 1 1
Approved: 2011/03/30
NDC:54868-3732
Mebendazole
Manufacturer:DARMERICA, LLC
Route:NOT APPLICABLE
Strength:1 kg in 1 kg
Approved: 2025/04/22
NDC:71052-169
Emverm
Manufacturer:Amneal Pharmaceuticals LLC
Route:ORAL
Strength:100 mg in 1 1
Approved: 2023/12/16
NDC:64896-669
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath